Rexinoids and breast cancer prevention.
Howe
Louise R
LR
Department of Cell and Developmental Biology, Weill Cornell Medical College, and Strang Cancer Research Laboratory, New York, New York 10065, USA. lrhowe@med.cornell.edu
D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000517:prevention & control*; D045744:Cell Line, Tumor; D002986:Clinical Trials as Topic; D019281:Dimerization; D004195:Disease Models, Animal; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008954:Models, Biological; D018168:Receptors, Retinoic Acid / Q000737:chemistry / Q000378:metabolism*; D014158:Transcription, Genetic
D016588:Anticarcinogenic Agents; D018168:Receptors, Retinoic Acid